产品说明
包装
1, 5 mg in glass bottle
生化/生理作用
Doxercalciferol is a Vitamin D2 analogue, a Vitamin D Receptor Activator (VDRA). Doxercalciferol acts as a pro-hormone, needing 25-hydroxylation in the liver for bioactivation into 1α, 25-hydroxyvitamin D2. Pivotal studies in adults on dialysis have demonstrated control of secondary hyperparathyroidism that is superior to placebo therapy, without undue suppression of 1st IMA-PTH < 300 pg/mL, or occurrences of hypercalcemia. Doxercalciferol has been shown to be effective in controlling secondary hyperparathyroidism of adult patients with CKD stages 3-4.
Doxercalciferol is a vitamin D2 analog that acts as a pro-hormone, activated in the liver to 1α,25-dihydroxyvitamin D2. Despite its relatively low affinity for the vitamin D receptor (VDR) (before activation), it is effective at suppressing expression of the parathyroid hormone (PTH) gene, and appears to act through the VDR.
基本信息
经验(实验)分子式 | C28H44O2 |
分子量 | 412.65 |
MDL编号 | MFCD00871065 |
PubChem化学物质编号 | 329798592 |
NACRES | NA.77 |
产品性质
质量水平 | 100 |
测定 | ≥98% (HPLC) |
形式 | powder |
储存条件 | desiccated |
溶解性 | DMSO: >10 mg/mL |
运输 | wet ice |
储存温度 | −20℃ |
SMILES string | CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2C(\CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C |
InChI | 1S/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1 |
InChI key | HKXBNHCUPKIYDM-CGMHZMFXSA-N |
Gene Information | human ... VDR(7421) |
安全信息
象形图 | |
警示用语: | Danger |
危险声明 | H300 |
预防措施声明 | P264 - P301 + P310 |
危险分类 | Acute Tox. 1 Oral |
储存分类代码 | 6.1B - Non-combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials |
WGK | WGK 3 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |